AMC-098: Nelfinavir Mesylate in Treating Patients With Kaposi Sarcoma (H-44430)
AMC-098: A Pilot Study of Nelfinavir for the Treatment of Kaposi Sarcoma
PURPOSE: This pilot phase II trial studies how well nelfinavir mesylate works in treating patients with kaposi sarcoma. Nelfinavir mesylate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
For more information: https://clinicaltrials.gov/ct2/show/NCT03077451